BRBilal Rabahoğlu

Bilal Rabahoğlu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bilal Rabahoğlu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Obstrüktif Uyku Apnesi Hastalarında Cinsiyet Temelli Klinik ve Polisomnografik Özellikler: On Yıllık Tek Merkez Deneyimi

    by Burcu Baran, Nur Aleyna Yetkin, Bilal Rabahoğlu, Nuri Tutar

    Amaç: Obstrüktif uyku apnesi (OUA), uykuda üst havayolunun tekrarlayan daralması veya tıkanması sonucu gelişen ve çok sayıda sistemik hastalıkla ilişkili yaygın bir solunum bozukluğudur. Cinsiyet, OUA’nın epidemiyolojisi, klinik sunumu ve uyku mimarisi üzerinde belirleyici bir faktör olarak tanımlanmaktadır. Bu çalışmada, son on yılda polisomnografi yapılan erişkin hastalarda OUA’nın klinik ve polisomnografik özelliklerinin cinsiyet açısından değerlendirilmesi amaçlanmıştır. Gereç ve Yöntemler: Bu retrospektif tanımlayıcı çalışma, Erciyes Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Anabilim Dalı Uyku Bozuklukları Merkezinde 2015–2025 yılları arasında polisomnografi yapılan 545 erişkin hastayı kapsamaktadır. Veriler hasta dosyalarından elde edilerek retrospektif olarak taranmıştır. Cinsiyetle ilgili farklılıkları belirlemek için demografik, klinik ve polisomnografi (PSG) parametreleri analiz edildi. Bulgular: Çalışmaya 346 erkek (%64) ve 199 kadın (%36) toplam 545 hasta dahil edilmiştir. Kadınlarda yaş ve vücut kitle indeksi (VKİ) anlamlı şekilde daha yüksek bulunmuştur (p<0,05). Erkeklerde boyun çevresi ve sigara kullanımı daha fazla, kadınlarda hipertansiyon, diyabet, astım ve hipotiroidizm oranları belirgin olarak yüksektir. Polisomnografik parametreler açısından Apne-hipopne indeksi ve oksijen satürasyon değerleri benzer bulunmuş, ancak kadınlarda N3 süresi daha uzun, erkeklerde N1–N2 süreleri daha belirgin saptanmıştır. Sonuç: OUA erkeklerde daha sık görülmekle birlikte, kadınlarda özellikle yaş artışı ile klinik önem kazanmaktadır. Kadınlarda VKİ yüksekliği ve komorbidite yükü, erkeklerde sigara kullanımı ve geniş boyun çevresi belirleyici risk faktörleridir. Cinsiyet temelli farklılıkların değerlendirilmesi, OUA yönetiminde bireyselleştirilmiş tedavi yaklaşımları açısından önem taşımaktadır.

  • Cihaz Konforundan Sosyal Desteğe: Obstrüktif Uyku Apnesi Hastalarında PAP Tedavisine Uyumun Çok Yönlü Belirleyicileri

    by Burcu Baran, Melike Serra Kumsar, Gamze Doğmaz, Nur Aleyna Yetkin, Bilal Rabahoğlu, Nuri Tutar, Fatma Sema Oymak, İnCi Gülmez

    Obstrüktif uyku apnesi tanısı alan ve pozitif havayolu basıncı tedavisi başlanan hastalarda cihaz kullanımına uyumu etkileyen demografik, klinik, çevresel ve psikososyal faktörlerin değerlendirilmesi amaçlanmıştır. Ocak 2020–Aralık 2024 tarihleri arasında uyku kliniğine başvuran, polisomnografi ile orta-ağır Obstrüktif uyku apnesi (OUA), tanısı konulan ve Pozitif havayolu basıncı (PAP) tedavisi başlanan hastalar retrospektif olarak incelendi. Toplam 337 hasta telefon ile arandı, 212’sine ulaşıldı ve 117’si onay vererek çalışmaya dahil edildi. Hastaların demografik özellikleri, komorbiditeleri, cihaz türü ve kullanım alışkanlıkları kaydedildi. Cihaz uyumu, en az 3 ay düzenli kullanım ve halen aktif kullanım olarak tanımlandı. Anketlerde bireysel, çevresel ve psikososyal faktörler beşli Likert ölçeği ile sorgulandı. Katılımcıların %68’i erkek olup, uyum oranı %67 olarak bulundu. Uyumlu grupta erkek cinsiyet (p=0.034) ve otomatik pozitif hava yolu basıncı (APAP) kullanımı (p

  • Open Access

    Integrated Assessment of Obesity Indices and Novel Inflammatory Biomarkers in Predicting the Severity of Obstructive Sleep Apnea

    by Burcu Baran, Filiz Miraç Şimşek, Hasan Durmuş, Nur Aleyna Yetkin, Bilal Rabahoğlu, Nuri Tutar, İnci Gülmez, Fatma Sema Oymak

    Background/Objectives: Obesity is a significant risk factor for obstructive sleep apnea (OSA); however, conventional anthropometric measures, such as body mass index (BMI), may not fully reflect the physiological burden associated with adiposity. The triponderal mass index (TMI) has been proposed as an alternative anthropometric indicator, while inflammation-related biomarkers have emerged as potential complementary tools for characterizing OSA severity. This study aimed to evaluate the relationships between BMI, TMI, hypoxemia, and systemic inflammation, and to assess whether combining anthropometric indices with inflammatory biomarkers improves the identification of severe OSA. Methods: In this retrospective cross-sectional study, 238 adults undergoing full-night polysomnography were classified into four groups: non-OSA, mild OSA, moderate OSA, and severe OSA, based on the apnea–hypopnea index (AHI). Anthropometric indices, polysomnographic parameters, and a comprehensive panel of laboratory biomarkers—including C-reactive protein (CRP), neutrophil- and platelet-derived inflammatory indices, prognostic nutritional index (PNI), CRP-to-albumin ratio (CAR), and CRP-to-lymphocyte ratio (CLR)—were analyzed. Associations were evaluated using Spearman correlation analyses, and diagnostic performance for severe OSA (AHI ≥ 30 events/h) was assessed using receiver operating characteristic (ROC) analyses, DeLong tests, and multivariable models. Results: Both BMI and TMI increased progressively with OSA severity (both p < 0.001) and showed comparable correlations with AHI and nocturnal oxygenation parameters. ROC analyses demonstrated similar discriminative performance for severe OSA (BMI AUC = 0.834; TMI AUC = 0.823; p = 0.229). Among inflammatory biomarkers, CRP, multi-inflammatory index (MII), CAR, and CLR showed moderate diagnostic accuracy. Among the evaluated markers, serum albumin (AUC = 0.836) and PNI demonstrated the highest diagnostic accuracy (AUC = 0.994). A combined model integrating BMI or TMI with PNI achieved near-perfect discrimination for severe OSA (BMI-based AUC = 0.9956; TMI-based AUC = 0.9969), while the addition of CRP-based inflammatory markers did not yield meaningful incremental benefit. Conclusions: BMI and TMI exhibit comparable performance in relation to OSA severity, hypoxemia, and systemic inflammation, with no clear superiority of TMI over BMI in adult patients. Inflammation-related biomarkers—particularly PNI—provide additional discriminatory value beyond anthropometric measures alone. Integrating simple biochemical markers with anthropometric and polysomnographic parameters may enhance risk stratification and identification of severe OSA phenotypes.


  • The role of pulse oximeter in anxiety and exacerbations in COPD patients: A prospective observational study

    by Nur Aleyna Yetki̇n, Fatma Yi̇ğİt Erarslan, Burcu Baran, Bilal Rabahoğlu, Nuri Tutar, İnCi Gülmez

    Pulse oximeter is commonly used by chronic obstructive pulmonary disease (COPD) patients for long-term oxygen therapy (LTOT) to monitor oxygen levels. This study investigated the association between oximeter use, anxiety severity, symptom burden, and healthcare utilization in this population. This prospective observational study included 110 individuals with COPD who underwent LTOT. Data were collected on pulmonary function, modified Medical Research Council (mMRC) scores, and daily pulse oximeter use. Anxiety severity was assessed using the Beck Anxiety Inventory (BAI). Healthcare utilization in the previous year, including outpatient-treated and inpatient-treated exacerbations, intensive care unit admissions, and non-exacerbation-related hospital admissions, was analyzed. Linear regression analysis was performed to identify the independent predictors of nonexacerbation-related hospital admissions. Among the participants, 68 (61.8%) reported using a home pulse oximeter. There were no significant differences in BAI scores (p= 0.678), oxygen therapy duration (p= 0.530), or mMRC scores (p= 0.251) between the groups. However, non-users had significantly higher rates of non-exacerbation-related hospital admissions than users (p< 0.001). In multivariable analysis, not using pulse oximeter independently predicted more non-exacerbationrelated admissions (B= 1.63, 95% CI: 0.94-2.32, p< 0.001), whereas anxiety and physiological measures were not significant. Pulse oximeter use was not associated with anxiety or symptom severity among the patients with COPD receiving LTOT. However, non-use of pulse oximeter was independently associated with increased non-exacerbation-related hospital admissions. These findings suggest that pulse oximeter may support patient self-management and reduce unnecessary healthcare utilization, without contributing to anxiety.


  • Open Access

    Tissue sample taken by transbronchial biopsy in the diagnosis of tuberculosis; benefits-risks

    by Bilal Rabahoğlu, Nuri Tutar, Burcu Baran, Nur A. Yetkin, Fatma S. Oymak, İnCi Gülmez

    Objectives: Tuberculosis (TB) poses a serious health risk in Turkey and globally and is often difficult to diagnose. It may be sometimes necessary to obtain bronchoalveolar lavage (BAL) and, in some cases, biopsy samples via bronchoscopy to acquire an adequate sample. Our aim is to assess the contribution of transbronchial lung biopsy (TBLB) alongside BAL in diagnosing TB. In addition, we will evaluate the risk of pneumothorax associated with TBLB and determine the overall risk–benefit ratio. Methods: Flexible fiberoptic bronchoscopy (FFB) reports performed for suspected TB between March 2011 and July 2018 were retrospectively reviewed. Patients who had both BAL and tissue samples taken via TBLB were included in the study. Of the 606 patients included, age, sex, the lung area where the biopsy was taken, BAL and biopsy AFB and culture results, and complications such as pneumothorax and chest tube application were recorded. Results: A total of 606 patients were included in the study. Of these, 391 patients were male (64.5%) and 215 were female (35.5%). A total of 37 (6.1%) patients had a positive culture for TB. Nineteen (59.4%) patients were positive on both BAL and tissue culture, while 5 patients were only positive on tissue culture. Pneumothorax developed in 34 patients (5.6%), 28 of whom required a chest tube. Conclusion: Using various modalities such as BAL and TBLB together for diagnosing pulmonary TB can be advantageous when appropriate, particularly given the absence of significant complications during the procedure. Our findings indicate that incorporating TBLB alongside BAL impacted the diagnosis of pulmonary TB.

  • Open Access

    Assessment of Mortality Risk in Patients With Community‐Acquired Pneumonia: Role of Novel Inflammatory Biomarkers

    by Burcu Baran, Nur Aleyna Yetkin, Bilal Rabahoğlu, Nuri Tutar, İnCi Gülmez

    Background: Pneumonia is a lung parenchyma infection with clinical presentations ranging from mild to life‐threatening. Its severity depends on factors such as the causative pathogen, the host's immune response, and existing comorbidities. This study aimed to investigate the prognostic value of novel inflammatory biomarkers for predicting in‐hospital mortality in patients with community‐acquired pneumonia (CAP).Methods: This retrospective cross‐sectional study included 207 hospitalized patients diagnosed with clinically and radiologically confirmed pneumonia. Laboratory data collected upon admission included complete blood count parameters, C‐reactive protein (CRP), creatinine, and albumin levels. Systemic inflammatory biomarkers such as the neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), CRP‐to‐albumin ratio (CAR), CRP‐to‐lymphocyte ratio (CLR), systemic immune‐inflammation index (SII), systemic inflammatory response index (SIRI), prognostic nutritional index (PNI), and C‐reactive protein‐albumin‐lymphocyte (CALLY) index were calculated.Results: The cohort was predominantly male (69%, n = 142) with a mean age of 62.1 ± 16.3 years. The median hospital stay was 8 days, with an 11% mortality rate. Malignancy was more frequent in the nonsurvivor group (p = 0.001). Nonsurvivors had significantly lower hemoglobin (p < 0.001) and albumin (p = 0.004) levels, while CRP (p = 0.024) and creatinine (p = 0.002) were elevated. NLR (p = 0.009), CAR (p = 0.011), CLR (p = 0.006), SII (p = 0.013), and SIRI (p = 0.024) were higher in nonsurvivors, while PNI (p = 0.010) and CALLY (p = 0.003) were lower.Conclusion: Novel inflammatory biomarkers, particularly the CALLY index, are valuable for mortality prediction in CAP, aiding in risk stratification and early management.


  • Open Access

    Endobronchial biopsies in patients receiving clopidogrel and aspirin treatment

    by Bilal Rabahoğlu, Nuri Tutar, Nur Aleyna Yetkin, Burcu Baran, İnCi Gülmez

    Some patients undergoing pulmonary procedures are on at least one antiplatelet or anticoagulant agent. Discontinuing these treatments can be challenging due to the risk of severe complications, particularly following acute coronary event. While studies indicate that clopidogrel cessation is necessary before transbronchial biopsy, others suggest it may be safely continued for procedures such as endobronchial ultrasound-guided transbronchial needle aspiration. There is limited literature on performing endobronchial biopsies while patients are on clopidogrel (a P2Y12 inhibitor), with only one case report available. In our three cases, the patients had endobronchial lesions causing partial or complete airway obstruction, leading to severe dyspnea and wheezing. Two of the patients were on dual antiplatelet therapy (DAPT) due to recent coronary artery syndrome treated with coronary stents, while the third was receiving the same treatment for peripheral artery disease managed with a stent. Endobronchial biopsies (EBB) were performed on all three patients without any major complications. Although it is typically recommended to discontinue clopidogrel 5–7 days prior to the procedure, early diagnosis and treatment are crucial in certain cases. In these situations, where the benefits may outweigh the risks, EBB can be performed with appropriate precautions. Through our case reports, we aim to encourage further prospective studies and the establishment of updated guidelines, particularly concerning EBB in patients receiving DAPT.

  • Open Access

    Evaluating the Reliability and Quality of Sarcoidosis-Related Information Provided by AI Chatbots

    by Nur Aleyna Yetkin, Burcu Baran, Bilal Rabahoğlu, Nuri Tutar, İnci Gülmez

    Background and Objectives: Artificial intelligence (AI) chatbots are increasingly employed for the dissemination of health information; however, apprehensions regarding their accuracy and reliability remain. The intricacy of sarcoidosis may lead to misinformation and omissions that affect patient comprehension. This study assessed the usability of AI-generated information on sarcoidosis by evaluating the quality, reliability, readability, understandability, and actionability of chatbot responses to patient-centered queries. Methods: This cross-sectional evaluation included 11 AI chatbots comprising both general-purpose and retrieval-augmented tools. Four sarcoidosis-related queries derived from Google Trends were submitted to each chatbot under standardized conditions. Responses were independently evaluated by four blinded pulmonology experts using DISCERN, the Patient Education Materials Assessment Tool—Printable (PEMAT-P), and Flesch–Kincaid readability metrics. A Web Resource Rating (WRR) score was also calculated. Inter-rater reliability was assessed using intraclass correlation coefficients (ICCs). Results: Retrieval-augmented models such as ChatGPT-4o Deep Research, Perplexity Research, and Grok3 Deep Search outperformed general-purpose chatbots across the DISCERN, PEMAT-P, and WRR metrics. However, these high-performing models also produced text at significantly higher reading levels (Flesch–Kincaid Grade Level > 16), reducing accessibility. Actionability scores were consistently lower than understandability scores across all models. The ICCs exceeded 0.80 for all evaluation domains, indicating excellent inter-rater reliability. Conclusions: Although some AI chatbots can generate accurate and well-structured responses to sarcoidosis-related questions, their limited readability and low actionability present barriers for effective patient education. Optimization strategies, such as prompt refinement, health literacy adaptation, and domain-specific model development, are required to improve the utility of AI chatbots in complex disease communication.


  • Sleep quality and risk of obstructive sleep apnea in psoriasis and hidradenitis suppurativa patients

    by Burcu Baran, Eda Öksüm Solak, Nur Aleyna Yetkin, Bilal Rabahoğlu, Nuri Tutar, İnCi Gülmez, Fatma Sema Oymak

    Background/aim Psoriasis and Hidradenitis Suppurativa (HS) are chronic inflammatory skin conditions that significantly impact quality of life, sleep, and increase morbidity. This study aims to compare sleep quality and the risk of obstructive sleep apnea (OSA) in patients with these conditions. Additionally, it explores the relationships between sleep disorders, demographic factors, disease severity, and inflammatory markers. Materials and methods The study included 25 HS and 50 psoriasis patients diagnosed and followed in the Dermatology Department of a tertiary healthcare institution. Disease severity was assessed using the HURLEY score for HS patients and the Psoriasis Area and Severity Index (PASI) for psoriasis patients. Sleep quality and OSA risk were evaluated using the Pittsburgh Sleep Quality Index (PSQI), Berlin, and STOP-Bang questionnaires. Results A total of 75 patients participated, with 50 in the psoriasis group and 25 in the HS group. Of the participants, %41 were female, with a mean age of 36.4 ± 12.7 years. HS patients had significantly higher PSQI and STOP-Bang scores compared to psoriasis patients (p = 0.001 and p = 0.003, respectively). No significant associations were found between disease severity and questionnaire scores in either condition. However, the rate of high-risk OSA was higher in males (p = 0.004) and more prevalent in HS patients than in psoriasis patients (%64 vs. %26, p = 0.002). Conclusion HS patients face a significantly higher risk for OSA due to factors like obesity, smoking, increased neck and waist circumference, and elevated inflammation. Routine assessment of OSA risk using tools like the PSQI, Berlin, and STOP-Bang questionnaires is recommended for these patients.


  • Open Access

    Pulmonary Mucormycosis with Endobronchial Involvement Complicated by Pleural Effusion

    by Bilal Rabahoğlu, Nuri Tutar, Hilal Bozkurt, Burcu Baran, Nur Aleyna Yetkin

    Background: Pulmonary mucormycosis is an infection caused by a fungus with a severe and often fatal course, with a mortality rate exceeding 50%. It can spread through blood or lymphatic fluids or by inhalation of sporangiospores. Immunocompromised patients are especially susceptible to this high mortality rate. Histopathology is used to identify nonseptate hyphae in tissue, and culture is used to confirm the diagnosis. Treatment usually involves a combination of aggressive surgery and medication. Case Report: A patient with diabetes mellitus received corticosteroid treatment for facial paralysis, which led to the diagnosis of pulmonary mucormycosis. Without requiring surgical resection, the patient was successfully treated with intravenous antifungal medication, along with intrabronchial and intrapleural liposomal amphotericin B. Conclusion: Pulmonary mucormycosis requires prompt diagnosis and treatment. Close monitoring of such infections may minimize the need for invasive procedures and lower mortality, particularly when endobronchial involvement accompanied by effusion is present.